A comprehensive analysis of adverse events in the first 30 days of phase 1 pediatric CAR T-cell trials.

Blood Adv · 2023 · PMC10514106 · PMID 37486616

Europe PMC DOI

hedged sentence

0.1300

closest p · 2.6× alpha

0.1300

boldest claim

The sentences

a slight trendP = .13not close (p > 0.1)

However, there was a slight trend toward greater number of AEs in those aged ≥18 years (median, 5 vs 3 and 2 in the youngest and middle cohorts, respectively; P = .13; Figure 4 C).

also in 977 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.